BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7999598)

  • 1. Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA.
    Speight EL; Farr PM
    Br J Dermatol; 1994 Nov; 131(5):667-72. PubMed ID: 7999598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
    Sakuntabhai A; Farr PM; Diffey BL
    Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
    Cox NH; Farr PM; Diffey BL
    Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapy.
    Smith G; Wilkie MJ; Deeni YY; Farr PM; Ferguson J; Wolf CR; Ibbotson SH
    Br J Dermatol; 2007 Dec; 157(6):1230-4. PubMed ID: 17916200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis.
    Brücke J; Tanew A; Ortel B; Hönigsmann H
    Br J Dermatol; 1991 Apr; 124(4):372-4. PubMed ID: 2025558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
    Calzavara-Pinton P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of psoriasis to twice weekly PUVA.
    Sakuntabhai A; Sharpe GR; Farr PM
    Br J Dermatol; 1993 Feb; 128(2):166-71. PubMed ID: 8457450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.
    Kirby B; Buckley DA; Rogers S
    Br J Dermatol; 1999 Apr; 140(4):661-6. PubMed ID: 10233317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between plasma psoralen concentration and psoralen-UVA erythema.
    Mclelland J; Fisher C; Farr PM; Diffey BL; Cox NH
    Br J Dermatol; 1991 Jun; 124(6):585-90. PubMed ID: 2064944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative UV radiation dose and outcome in clinical practice: effectiveness of trioxsalen bath PUVA with minimal UVA exposure.
    Snellman E; Rantanen T; Sundell J
    Photodermatol Photoimmunol Photomed; 2000 Oct; 16(5):207-10. PubMed ID: 11068859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum erythema dose determination in individuals of skin type V and VI with diffuse reflectance spectroscopy.
    Kollias N; Baqer A; Sadiq I
    Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):249-54. PubMed ID: 7727281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of actinic prurigo with PUVA: mechanism of action.
    Farr PM; Diffey BL
    Br J Dermatol; 1989 Mar; 120(3):411-8. PubMed ID: 2713261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair elicited by UVB during PUVA therapy for psoriasis.
    Bishop SC; Abel EA
    Arch Dermatol Res; 1985; 278(1):25-30. PubMed ID: 4096527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis.
    Grundmann-Kollmann M; Ludwig R; Zollner TM; Ochsendorf F; Thaci D; Boehncke WH; Krutmann J; Kaufmann R; Podda M
    J Am Acad Dermatol; 2004 May; 50(5):734-9. PubMed ID: 15097957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
    Al-Ismail D; Edwards C; Anstey AV
    Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoprotection due to pigmentation and epidermal thickness after repeated exposure to ultraviolet light and psoralen plus ultraviolet A therapy.
    Bech-Thomsen N; Wulf HC
    Photodermatol Photoimmunol Photomed; 1995; 11(5-6):213-8. PubMed ID: 8738717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of minimal phototoxic dose and skin type for determining initial UVA dose in oral liquid methoxsalen photochemotherapy for the treatment of psoriasis.
    Rafal ES; Hamilton TA; Gonzalez E
    J Invest Dermatol; 1991 Dec; 97(6):1048-52. PubMed ID: 1748814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of psoralen - UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Coll Physicians Surg Pak; 2004 Oct; 14(10):593-5. PubMed ID: 15456547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action spectrum between 320 and 400 nm for clearance of psoriasis by psoralen photochemotherapy.
    Farr PM; Diffey BL; Higgins EM; Matthews JN
    Br J Dermatol; 1991 May; 124(5):443-8. PubMed ID: 2039720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.